Zhenbin Li
Impact in
-
- Natural Compounds in Disease Treatment
-
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
- Osteoarthritis Treatment and Mechanisms 1
-
- Sphingolipid Metabolism and Signaling 1
- Co-authors
- Zhuoli Zhang (1 shared paper)Dong Xu (1 shared paper)Yan Zhao (2 shared papers)Qingjun Wu (2 shared papers)Yuan Wang (1 shared paper)Xu D (1 shared paper)Wei Liu (1 shared paper)Ying Jiang (1 shared paper)
- Journals
- Chinese Medicine (2 papers)Saudi Journal of Biological Sciences (1 paper)Clinical Immunology (1 paper)Scientific Reports (1 paper)PubMed (2 papers)
- Partner nations
- China
In The Last Decade
Zhenbin Li
6 papers receiving 15 citations
Peers
Comparison fields: 5 of 12
- Complementary and alternative medicine 5
- Rheumatology 7
- Immunology and Allergy 2
- Immunology 4
- Hematology 2
Countries citing papers authored by Zhenbin Li
This map shows the geographic impact of Zhenbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenbin Li more than expected).
Fields of papers citing papers by Zhenbin Li
This network shows the impact of papers produced by Zhenbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenbin Li. The network helps show where Zhenbin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenbin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2020 | 4 | |
| 3 | 2023 | 2 | |
| 4 | [Clinical effect analysis of ankylosing spondylitis treated by Chinese medical syndrome differentiation]. | 2013 | 2 |
| 5 | 2018 | 1 | |
| 6 | [An open-label, multicentric clinical trial to evaluate the efficacy and impact on bone metabolism of recombinant human tumor necrosis factor-α receptor II IgG Fc fusion protein with methotrexate in active rheumatoid arthritis: 24-week clinical and radiographic results from ReABLE study]. | 2010 | 1 |
| 7 | 2024 | 1 |
About Zhenbin Li
Zhenbin Li is a scholar working on Rheumatology, Molecular Biology, Genetics, Neurology and Complementary and alternative medicine, having authored 7 papers that have together received 16 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (2 papers), Sphingolipid Metabolism and Signaling (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Asthma and respiratory diseases (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Natural Compounds in Disease Treatment (1 paper) and Peripheral Neuropathies and Disorders (1 paper). The work is most often cited by research in Complementary and alternative medicine (5 citations), Rheumatology (7 citations), Immunology and Allergy (2 citations), Immunology (4 citations) and Hematology (2 citations). Zhenbin Li has collaborated with scholars based in China. Frequent co-authors include Zhuoli Zhang, Dong Xu, Yan Zhao, Qingjun Wu, Yuan Wang, Xu D, Wei Liu, Ying Jiang, Shumin Zhang and Yudong Liu. Their work appears in journals such as Chinese Medicine, Saudi Journal of Biological Sciences, Clinical Immunology, Scientific Reports and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.